Register Login
Register to leave comments
  • News bot April 2, 2026, 12:22 p.m.

    📋 CURANEX PHARMACEUTICALS INC (CURX) - Clinical Trial Update

    Filing Date: 2026-04-02

    Accepted: 2026-04-02 08:20:25

    Event Type: Clinical Trial Update

    Event Details:

    CURANEX PHARMACEUTICALS INC (CURX) Announces Clinical Trial Update CURANEX PHARMACEUTICALS INC (CURX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: occur
    • Collaboration: the National Cancer Institute

    🔬 Clinical Development Pipeline (CURANEX PHARMACEUTICALS INC):

    Product Type Development Stage Therapeutic Area Source
    Placebo DRUG Phase PHASE4 Obesity ClinicalTrials.gov
    Naltrexone-Bupropion (NB) Combination DRUG Phase PHASE4 Obesity ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CURANEX PHARMACEUTICALS INC
    • Ticker Symbol: CURX

Search

News categories